Académique Documents
Professionnel Documents
Culture Documents
GEETA MOHAN
GRAFT REJECTION
• Transplant rejection occurs when transplanted tissue is
rejected by the recipient's immune system, which
destroys the transplanted tissue.
• Transplant rejection can be lessened by determining the
molecular similitude between donor and recipient and
by use of immunosuppressant drugs after transplant.
• The presence of a foreign tissue evokes humeral and
cellular immune response. The presence of MHC
molecules on the graft tissue evokes this response.
(The major histocompatibility complex (MHC) is a set of
cell surface proteins essential for the acquired immune
system to recognize foreign molecules in vertebrates,
which in turn determines histocompatibility)
GRAFT REJECTION
• Acute rejection
Developing with formation of cellular immunity, acute
rejection occurs to some degree in all transplants, except
between identical twins, unless immunosuppression is
achieved (usually through drugs).
Acute rejection begins as early as one week after transplant,
the risk being highest in the first three months, though it can
occur months to years later. Highly vascular tissues such as
kidney or liver often host the earliest signs—particularly
at endothelial cells lining blood vessels—though it eventually
occurs in roughly 10 to 30% of liver transplants, and 10 to
20% of kidney transplants .
It is believed that the process of acute rejection is mediated
by the cell mediated pathway, specifically by mononuclear
macrophages and T-lymphocytes.
GRAFT REJECTION
• Chronic rejection
The term chronic rejection initially described long-
term loss of function in transplanted organs
via fibrosis of the transplanted tissue's blood
vessels.
Recurrent episodes lead to chronic rejection.
Chronic rejection explains long-term morbidity in
most lung-transplant recipients, the median survival
rate is roughly 4 - 7 years .
GRAFT REJECTION
A. Sensitization phase
• This is the first step in graft rejection. The antigen on the
allograft provokes the proliferation of the T lymphocytes.
The immune system of the recipient recognizes the MHC
molecules (major histocompatibility complex ) on the graft tissue.
• There is also the recognition of an associated peptide
molecule in the groove of the allogenic class I MHC
molecule which is produced inside the cell.
• CD4+ and CD8+ (cluster of differenciation ) cells recognize
alloantigens expressed on cells of foreign graft and
induces T cell proliferation in the host
• In some grafts such as kidney and pancreas the donor
antigen presenting cells (ACP) or dendritic cells are called
passenger leucocytes because they migrate from the graft
to the lymph node of that region. The passenger
leucocytes have excess dose of MHC class II molecules
and a normal dose of class I MHC molecule. This
stimulates the T cells in the lymph node. The T cells are
responsible for the other effector immune responses.
GRAFT REJECTION
B. Effector phase
• The second step in graft rejection involves the
following processes-
• There is delayed type hypersensitivity.
• Cytotoxic T lymphocytes mediated cytotoxicity.
• Antibody –antigen reaction and complement lysis.
• Destruction caused by cell mediated cytotoxicity.
• There is entry of T cells and macrophages. There is
production of cytokines by T cells.
The immune responses mentioned above cause the
destruction of graft tissue
GRAFT REJECTION
Reference / Acknowledgement
Wiki pedia
Google